Trial · NCT02709109
Participant flow36
How many started, completed or left each group, period by period.
1 to 20 of 36
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period 1 (28 Days) | STARTED | Sequence 1: VX-371 + HS, Then HS | 49 | |
| Treatment Period 1 (28 Days) | STARTED | Sequence 2: HS, Then VX-371 + HS | 47 | |
| Treatment Period 1 (28 Days) | STARTED | Sequence 3: VX-371 + Placebo, Then Placebo | 22 | |
| Treatment Period 1 (28 Days) | STARTED | Sequence 4: Placebo, Then VX-371 + Placebo | 24 | |
| Treatment Period 1 (28 Days) | COMPLETED | Sequence 1: VX-371 + HS, Then HS | 45 | |
| Treatment Period 1 (28 Days) | COMPLETED | Sequence 2: HS, Then VX-371 + HS | 42 | |
| Treatment Period 1 (28 Days) | COMPLETED | Sequence 3: VX-371 + Placebo, Then Placebo | 21 | |
| Treatment Period 1 (28 Days) | COMPLETED | Sequence 4: Placebo, Then VX-371 + Placebo | 24 | |
| Treatment Period 1 (28 Days) | NOT COMPLETED | Sequence 1: VX-371 + HS, Then HS | 4 | |
| Treatment Period 1 (28 Days) | NOT COMPLETED | Sequence 2: HS, Then VX-371 + HS | 5 | |
| Treatment Period 1 (28 Days) | NOT COMPLETED | Sequence 3: VX-371 + Placebo, Then Placebo | 1 | |
| Treatment Period 1 (28 Days) | NOT COMPLETED | Sequence 4: Placebo, Then VX-371 + Placebo | 0 | |
| Washout Period (28 Days) | STARTED | Sequence 1: VX-371 + HS, Then HS | 45 | |
| Washout Period (28 Days) | STARTED | Sequence 2: HS, Then VX-371 + HS | 42 | |
| Washout Period (28 Days) | STARTED | Sequence 3: VX-371 + Placebo, Then Placebo | 21 | |
| Washout Period (28 Days) | STARTED | Sequence 4: Placebo, Then VX-371 + Placebo | 24 | |
| Washout Period (28 Days) | COMPLETED | Sequence 1: VX-371 + HS, Then HS | 43 | |
| Washout Period (28 Days) | COMPLETED | Sequence 2: HS, Then VX-371 + HS | 40 | |
| Washout Period (28 Days) | COMPLETED | Sequence 3: VX-371 + Placebo, Then Placebo | 18 | |
| Washout Period (28 Days) | COMPLETED | Sequence 4: Placebo, Then VX-371 + Placebo | 24 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02709109/flow